Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Axter Therapeutics (beijing) Co., Ltd

Clinical trials sponsored by Axter Therapeutics (beijing) Co., Ltd, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New oral cancer drug enters first human safety trial Results expected Mar 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New oral cancer drug enters first human safety trial

Disease control Recruiting now

This early-stage study tests a new oral drug, AXT-1003, in 78 people with advanced non-Hodgkin lymphoma or solid tumors that have not responded to standard treatments. The main goal is to check safety and find the right dose. Researchers will also look for signs that the drug shr…

Phase 1 • Sponsor: Axter Therapeutics (Beijing) Co., Ltd • Aim: Disease control

Last updated Jun 27, 2026 09:00 UTC